FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063556517> ?p ?o ?g. }

• W2063556517 endingPage "555" @default.
• W2063556517 startingPage "551" @default.
• W2063556517 abstract "BACKGROUND. This study summarizes long-term outcomes from treatment of prostate cancer with increased risk of extracapsular cancer extension (ECE) using brachytherapy-based treatment. METHODS. A total of 282 consecutive patients were treated from 1992–1996 by 1 author (M.D.). Two hundred forty-three patients had at least 1 higher risk feature for ECE including Gleason Score 7–10 (172), prostate-specific antigen (PSA) above 10 (166), and clinical stages T2c (109) and T3 (107). Using National Comprehensive Cancer Network (NCCN) guidelines, 119 patients had intermediate-risk disease and 124 had high-risk disease. Patients received pelvic 3-dimensional conformal external beam radiation followed by a palladium (Pd)-103 boost. Generous brachytherapy margins were utilized. Biochemical failure was defined using ASTRO Consensus Definition, nadir +2 and PSA >0.2 ng/mL at last follow-up. The nonfailing patient follow-up period was 1–14 years (median, 9.5 years). Biochemical data and original biopsy slides were independently re-reviewed at the University of Washington (by K.W. and L.T., respectively). RESULTS. Overall actuarial freedom from biochemical progression at 14 years was 81%, including 87% and 72% having intermediate and high-risk disease, respectively. Absolute risk of failure decreased progressively, falling to 1% beyond 6 years after treatment. All failing patients had prostate biopsies without evidence of local recurrence. The strongest predictor of failure was Gleason score (P = .03) followed by PSA (P = .041). Treatment morbidity was limited to temporary RTOG grade 1–2 urinary and gastrointestinal symptoms. CONCLUSIONS. High tumor control rates are possible with beam radiation followed by Pd-103 brachytherapy. Despite perceptions that brachytherapy is inappropriate for patients at higher risk for ECE, this series strengthens the rationale that brachytherapy-based treatment may be a desirable modality for such patients. Cancer 2007. © 2007 American Cancer Society." @default.
• W2063556517 created "2016-06-24" @default.
• W2063556517 creator A5025531958 @default.
• W2063556517 creator A5029570931 @default.
• W2063556517 creator A5034997866 @default.
• W2063556517 creator A5040789807 @default.
• W2063556517 creator A5041281661 @default.
• W2063556517 date "2007-01-01" @default.
• W2063556517 modified "2023-10-17" @default.
• W2063556517 title "Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features" @default.
• W2063556517 cites W1548008213 @default.
• W2063556517 cites W1899295031 @default.
• W2063556517 cites W1996490151 @default.
• W2063556517 cites W2006521105 @default.
• W2063556517 cites W2026853653 @default.
• W2063556517 cites W2028159286 @default.
• W2063556517 cites W2059132676 @default.
• W2063556517 cites W2061407198 @default.
• W2063556517 cites W2089524926 @default.
• W2063556517 cites W2092804733 @default.
• W2063556517 cites W2093580315 @default.
• W2063556517 cites W2094355364 @default.
• W2063556517 cites W2096421124 @default.
• W2063556517 cites W2117792530 @default.
• W2063556517 cites W2125168442 @default.
• W2063556517 cites W2128289067 @default.
• W2063556517 cites W2134766389 @default.
• W2063556517 cites W2138320929 @default.
• W2063556517 cites W2148386014 @default.
• W2063556517 cites W4294344900 @default.
• W2063556517 doi "https://doi.org/10.1002/cncr.22810" @default.
• W2063556517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17577217" @default.
• W2063556517 hasPublicationYear "2007" @default.
• W2063556517 type Work @default.
• W2063556517 sameAs 2063556517 @default.
• W2063556517 citedByCount "52" @default.
• W2063556517 countsByYear W20635565172012 @default.
• W2063556517 countsByYear W20635565172013 @default.
• W2063556517 countsByYear W20635565172014 @default.
• W2063556517 countsByYear W20635565172016 @default.
• W2063556517 countsByYear W20635565172017 @default.
• W2063556517 countsByYear W20635565172020 @default.
• W2063556517 countsByYear W20635565172022 @default.
• W2063556517 crossrefType "journal-article" @default.
• W2063556517 hasAuthorship W2063556517A5025531958 @default.
• W2063556517 hasAuthorship W2063556517A5029570931 @default.
• W2063556517 hasAuthorship W2063556517A5034997866 @default.
• W2063556517 hasAuthorship W2063556517A5040789807 @default.
• W2063556517 hasAuthorship W2063556517A5041281661 @default.
• W2063556517 hasBestOaLocation W20635565171 @default.
• W2063556517 hasConcept C121608353 @default.
• W2063556517 hasConcept C126322002 @default.
• W2063556517 hasConcept C126894567 @default.
• W2063556517 hasConcept C141071460 @default.
• W2063556517 hasConcept C143998085 @default.
• W2063556517 hasConcept C2775934546 @default.
• W2063556517 hasConcept C2776235491 @default.
• W2063556517 hasConcept C2777416452 @default.
• W2063556517 hasConcept C2780192828 @default.
• W2063556517 hasConcept C509974204 @default.
• W2063556517 hasConcept C71924100 @default.
• W2063556517 hasConceptScore W2063556517C121608353 @default.
• W2063556517 hasConceptScore W2063556517C126322002 @default.
• W2063556517 hasConceptScore W2063556517C126894567 @default.
• W2063556517 hasConceptScore W2063556517C141071460 @default.
• W2063556517 hasConceptScore W2063556517C143998085 @default.
• W2063556517 hasConceptScore W2063556517C2775934546 @default.
• W2063556517 hasConceptScore W2063556517C2776235491 @default.
• W2063556517 hasConceptScore W2063556517C2777416452 @default.
• W2063556517 hasConceptScore W2063556517C2780192828 @default.
• W2063556517 hasConceptScore W2063556517C509974204 @default.
• W2063556517 hasConceptScore W2063556517C71924100 @default.
• W2063556517 hasIssue "3" @default.
• W2063556517 hasLocation W20635565171 @default.
• W2063556517 hasLocation W20635565172 @default.
• W2063556517 hasOpenAccess W2063556517 @default.
• W2063556517 hasPrimaryLocation W20635565171 @default.
• W2063556517 hasRelatedWork W2016426829 @default.
• W2063556517 hasRelatedWork W2075763133 @default.
• W2063556517 hasRelatedWork W2088520467 @default.
• W2063556517 hasRelatedWork W2376423713 @default.
• W2063556517 hasRelatedWork W2389281101 @default.
• W2063556517 hasRelatedWork W2407572472 @default.
• W2063556517 hasRelatedWork W2411709837 @default.
• W2063556517 hasRelatedWork W3107042173 @default.
• W2063556517 hasRelatedWork W4240628612 @default.
• W2063556517 hasRelatedWork W1583600832 @default.
• W2063556517 hasVolume "110" @default.
• W2063556517 isParatext "false" @default.
• W2063556517 isRetracted "false" @default.
• W2063556517 magId "2063556517" @default.
• W2063556517 workType "article" @default.